Medical Market Report

Global Hemoglobin A1c Monitoring Market By Type (Ion-exchange, High-performance liquid chromatography (HPLC), Immunoassay, Boronate affinity chromatography, and Direct enzymatic assay), By Application (HbA1c Laboratory Testing, and HbA1c Point of Care Testing), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 138920
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Hemoglobin A1c Monitoring Market is estimated to be valued US$ XX.X million in 2019. The report on Hemoglobin A1c Monitoring Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global hemoglobin a1c monitoring market is segmented on the basis of Type, Application, and geography.

    Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.

    Hemoglobin A1c Monitoring Market Scope:

    By type, the market is segmented into Ion-exchange, High-performance liquid chromatography (HPLC), Immunoassay, Boronate affinity chromatography, and Direct enzymatic assay. By Application, the market is divided into HbA1c Laboratory Testing, and HbA1c Point of Care Testing.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Bayer Healthcare Diabetes Care (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Axis-Shield plc (UK), Beckman Coulter (US), Bio-Rad Laboratories Inc (US), Diazyme Laboratories Inc. (US), EKF Diagnostics Holdings Plc (UK), HEMOCUE(r) AB (Sweden), Infopia Co. Ltd. (South Korea), Menarini Diagnostics Ltd. (UK), Siemens Healthcare Diagnostics (Germany), Tosoh Bioscience Inc (US), Trinity Biotech plc (Ireland), and ARKRAY (Japan).

    Key Market Segments

    Type

    Ion-exchange

    High-performance liquid chromatography (HPLC)

    Immunoassay

    Boronate affinity chromatography

    Direct enzymatic assay

    Application

    HbA1c Laboratory Testing

    HbA1c Point of Care Testing

    Key Market Players included in the report:

    Bayer Healthcare Diabetes Care (US)

    Abbott Laboratories (US)

    Roche Diagnostics (Switzerland)

    Axis-Shield plc (UK)

    Beckman Coulter (US)

    Bio-Rad Laboratories Inc (US)

    Diazyme Laboratories Inc. (US)

    EKF Diagnostics Holdings Plc (UK)

    HEMOCUE(r) AB (Sweden)

    Infopia Co. Ltd. (South Korea)

    Menarini Diagnostics Ltd. (UK)

    Siemens Healthcare Diagnostics (Germany)

    Tosoh Bioscience Inc (US)

    Trinity Biotech plc (Ireland)

    ARKRAY (Japan)

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Hemoglobin A1c Monitoring Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Hemoglobin A1c Monitoring Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Hemoglobin A1c Monitoring Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Hemoglobin A1c Monitoring Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Hemoglobin A1c Monitoring Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Hemoglobin A1c Monitoring Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Hemoglobin A1c Monitoring sub-markets, depending on key regions (various vital states).
    To analyze Hemoglobin A1c Monitoring Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Hemoglobin A1c Monitoring Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Hemoglobin A1c Monitoring Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Hemoglobin A1c Monitoring Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    

    2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players
    

    3. Global Hemoglobin A1c Monitoring Market Overview
    

    3.1. Hemoglobin A1c Monitoring Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
    

      3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy
    

    4. Global Hemoglobin A1c Monitoring Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Hemoglobin A1c Monitoring Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Ion-exchange
    

      4.4. High-performance liquid chromatography (HPLC)
    

      4.5. Immunoassay
    

      4.6. Boronate affinity chromatography
    

      4.7. Direct enzymatic assay
    

    5. Global Hemoglobin A1c Monitoring Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Hemoglobin A1c Monitoring Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. HbA1c Laboratory Testing
    

      5.4. HbA1c Point of Care Testing
    

    6. Global Hemoglobin A1c Monitoring Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Hemoglobin A1c Monitoring Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Hemoglobin A1c Monitoring Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Hemoglobin A1c Monitoring Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Hemoglobin A1c Monitoring Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Hemoglobin A1c Monitoring Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    

    7. Global Hemoglobin A1c Monitoring Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Bayer Healthcare Diabetes Care (US)
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
    

      7.4. Abbott Laboratories (US)
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
    

      7.5. Roche Diagnostics (Switzerland)
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
    

      7.6. Axis-Shield plc (UK)
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
    

      7.7. Beckman Coulter (US)
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
    

      7.8. Bio-Rad Laboratories Inc (US)
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

      7.9. Diazyme Laboratories Inc. (US)
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

      7.10. EKF Diagnostics Holdings Plc (UK)
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
    

      7.11. HEMOCUE(r) AB (Sweden)
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
    

      7.12. Infopia Co. Ltd. (South Korea)
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
    

      7.13. Menarini Diagnostics Ltd. (UK)
    

        7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments
    

      7.14. Siemens Healthcare Diagnostics (Germany)
    

        7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments
    

      7.15. Tosoh Bioscience#Inc (US)
    

        7.15.1. Company Overview
    
    7.15.2. Financial Highlights
    
    7.15.3. Product Portfolio
    
    7.15.4. SWOT Analysis
    
    7.15.5. Key Strategies and Developments
    

      7.16. Trinity Biotech plc (Ireland)
    

        7.16.1. Company Overview
    
    7.16.2. Financial Highlights
    
    7.16.3. Product Portfolio
    
    7.16.4. SWOT Analysis
    
    7.16.5. Key Strategies and Developments
    

      7.17. ARKRAY (Japan)
    

        7.17.1. Company Overview
    
    7.17.2. Financial Highlights
    
    7.17.3. Product Portfolio
    
    7.17.4. SWOT Analysis
    
    7.17.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.